Beijing Ql Biopharmaceutical Co.,ltd

This study tests a new drug, zovaglutide, to help adults with overweight or obesity lose weight. About 744 people will receive either the drug or a placebo for 52 weeks. The main goal is to see how much weight they lose and if at least 5% of body weight is lost.

This early-stage study looks at whether ZT002, a new long-acting drug for weight management, changes how the body processes four common medications (metformin, warfarin, rosuvastatin, and digoxin). About 60 healthy overweight or obese adults aged 18–45 will take these drugs with …